Robert J. Spiegel, Chief Medical Officer at PTC THERAPEUTICS, INC. (PTCT), sold 1,030 shares at $75.95 ($77K) on 2015-03-13, disclosed to the SEC on 2015-03-13.
Scheduled sale ($77k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.10 | 1,028 | $77K | 99.8% |
| 2 | $75.95 | 2 | $152 | 0.2% |
| Total | $75.10 avg | 1,030 | $77K | 100% |
| Filing → |
| PTCT | SELL | 2014-03-14 | $38K | — | Filing → |